EP Patent

EP1856029A1 — Crystalline acat inhibitor

Assigned to Medicis Pharmaceutical Corp · Expires 2007-11-21 · 18y expired

What this patent protects

The invention is directed to the Form A polymorph of N-benzyl-N'-(2,6diisopropyl-phenyl)-N-isopropyl-malonamide and its use as a therapeutic/cosmetic agent.

USPTO Abstract

The invention is directed to the Form A polymorph of N-benzyl-N'-(2,6diisopropyl-phenyl)-N-isopropyl-malonamide and its use as a therapeutic/cosmetic agent.

Drugs covered by this patent

olodaterol-hydrochloride (OLODATEROL HYDROCHLORIDE)

Patent Metadata

Patent number: EP1856029A1
Jurisdiction: EP
Classification: —
Expires: 2007-11-21
Drug substance claim: No
Drug product claim: No
Assignee: Medicis Pharmaceutical Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.